Mass General Brigham Innovation Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
29
- Investments
-
47
- Portfolio
-
6
- Exits
-
33
Mass General Brigham Innovation General Information
Description
Partners HealthCare Innovation is a corporate venture arm of Partners Healthcare based in Boston, Massachusetts. The firm specializes in the commercialization of new medical technologies from Partners' academic medical centers. The firm brings together specialists in medical technology licensing, research contracts, ventures, and business development. The firm also partners with investigators, scientists, and clinicians to translate new medical technology into healthcare practice via a variety of business channels.
Contact Information
Formerly Known As
Partners HealthCare Innovation
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- One Main Street
- Suite 510
- Cambridge, MA 02142
- United States
+1 (857) 000-0000
Mass General Brigham Innovation Investments & Acquisitions (47)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Verve Therapeutics | 14-Jan-2021 | Early Stage VC | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
| 000000 | 07-Jan-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 000000 0000000 00.0 |
| 00000000 000000000 | 26-Oct-2020 | 00000 00000 | 00000 | Drug Discovery | Startup | |
| 0000000 000000 | 08-May-2019 | 00000 00000 | 000.00 | Information Services (B2C) | Generating Revenue | |
| 0000000000 | 21-Jun-2017 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| 0000000 0000000000 | 01-Dec-2016 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
| 0000000 0000000000 | 24-May-2016 | 00000 00000 | 000.00 | Diagnostic Equipment | Out of Business | 00000 000000000 |
| 000000000 | 27-Apr-2016 | 00000 00000 | 000 | Other Devices and Supplies | Generating Revenue | |
| ImmuneXcite | 30-Mar-2016 | Later Stage VC | 00.00 | Biotechnology | Out of Business | |
| Health Catalyst | 18-Feb-2016 | Later Stage VC | 0000 | Other Healthcare Technology Systems | Generating Revenue/Not Profitable |
Mass General Brigham Innovation Exits (33)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Verve Therapeutics | 17-Jun-2021 | IPO | 00000 |
| 00000000000 (00000 | 01-Feb-2021 | 000000000 00000000 | |
| 00000000000 | 30-Oct-2020 | 000 00 00000000 | |
| 000000000 0000000 | 16-Oct-2020 | 0000000000: 000000 | |
| 0000000 0000000000 | 20-Apr-2020 | 000 00 00000000 | |
| 000000000 00000000 | 01-Oct-2019 | 000 00 00000000 | |
| 000000 00000000 | 25-Jul-2019 | 000 | 00000 |
| 0000000000 | 02-Nov-2018 | 000000000000000000 | 00.00 |
| Exosome Diagnostics | 01-Aug-2018 | Merger/Acquisition | 00000 |
| XTuit Pharmaceuticals | 01-Mar-2018 | Out of Business |
Mass General Brigham Innovation Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Mass General Brigham Innovation Team (72)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Beth Mollineaux | General Manager, Marketing & Communications, Innovation | Cambridge, MA | |||
| Diana Schwartzstein | Managing Director, Administration and Strategy | Cambridge, MA | |||
| Bruce Tedeschi Ph.D | Director, Intellectual Property & Senior IP Manager | Cambridge, MA | |||
| Michael Band | Business Development Manager | Cambridge, MA | |||
| Nimra Taqi | Director, Business Development & Licensing | Cambridge, MA |
Mass General Brigham Innovation Co-Investors (32)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| GV | 2 | 0 |
|
|
|
| RA Capital Management | 0 | 0 |
|
|
|
| Abingworth | 0 |
|
|
||
| Atlas Venture | 0 | 0 |
|
|
|
| Citadel Enterprise Americas | 0 |
|
|